share_log

Ardelyx | 4: Statement of changes in beneficial ownership of securities-Officer Williams Laura A

Ardelyx | 4：持股变动声明-高管 Williams Laura A

SEC announcement ·  02/22 16:58
Moomoo AI 已提取核心信息
Ardelyx, Inc.'s Chief Medical Officer, Laura A. Williams, completed a sale of company stock on February 20, 2024. The transaction involved 4,803 shares of Ardelyx common stock at a price of $8.7463 per share, resulting in a total sale value of $42,008.48. Following the sale, Williams holds a total of 380,138 Ardelyx shares directly. The sale was conducted in the open market.
Ardelyx, Inc.'s Chief Medical Officer, Laura A. Williams, completed a sale of company stock on February 20, 2024. The transaction involved 4,803 shares of Ardelyx common stock at a price of $8.7463 per share, resulting in a total sale value of $42,008.48. Following the sale, Williams holds a total of 380,138 Ardelyx shares directly. The sale was conducted in the open market.
Ardelyx, Inc. '的首席医疗官劳拉·威廉姆斯于2024年2月20日完成了公司股票的出售。该交易涉及4,803股Ardelyx普通股，价格为每股8.7463美元，总销售价值为42,008.48美元。出售后，威廉姆斯直接持有总计380,138股Ardelyx股票。此次出售是在公开市场上进行的。
Ardelyx, Inc. '的首席医疗官劳拉·威廉姆斯于2024年2月20日完成了公司股票的出售。该交易涉及4,803股Ardelyx普通股，价格为每股8.7463美元，总销售价值为42,008.48美元。出售后，威廉姆斯直接持有总计380,138股Ardelyx股票。此次出售是在公开市场上进行的。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息